SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/05/23 Wearable Devices Ltd. S-8 9/05/23 4:234K EdgarAgents LLC/FA |
Document/Exhibit Description Pages Size 1: S-8 Registration Statement - Securities for an HTML 63K Employee Benefit Plan 2: EX-5.1 Opinion of Sullivan & Worcester Tel Aviv (Har-Even HTML 10K & Co.), Israeli Counsel to Wearable Devices Ltd 3: EX-23.1 Consent of Ziv Haft, Certified Public Accountants, HTML 6K Isr., Bdo Member Firm, An Independent Registered Public Accounting Firm 4: EX-FILING FEES Filing Fee Table HTML 17K
Page | (sequential) | (alphabetic) | ↑Top | ||
---|---|---|---|---|---|
1 | 1st Page – Filing Submission | ||||
" | Power of Attorney (included on signature page) |
As filed with the Securities and Exchange Commission on September 5, 2023
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
WEARABLE DEVICES LTD.
(Exact name of registrant as specified in its charter)
State of Israel | Not applicable | |
(State or other jurisdiction
of incorporation or organization) |
(I.R.S. Employer Identification No.) |
2 Ha-Ta’asiya Street, Yokne’am Illit, 2069803 Israel
(Address of Principal Executive Offices)
Wearable Devices Ltd. 2015 Share Option Plan
(Full title of the plan)
Mudra Wearable, Inc.
24A Trolley Square #2203
(Name, Address and Telephone Number of Agent for Service)
COPIES TO:
Oded Har-Even, Esq. | Reut Alfiah, Adv. | |
Howard Berkenblit, Esq. Sullivan & Worcester LLP 1633 Broadway Tel: 212.660.3000 |
Sullivan & Worcester Tel-Aviv (Har-Even & Co.) HaArba’a Towers 28 HaArba’a St. North Tower, 35th floor Tel-Aviv,
Israel 6473925 |
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☐ | Accelerated filer ☐ | |
Non-accelerated filer ☐ | Smaller reporting company ☐ | |
Emerging growth company ☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☒
EXPLANATORY NOTE
On February 17, 2023, Wearable Devices Ltd., an Israeli company (the “Registrant”), filed a Registration Statement on Form S-8 (File No. 333-269869) (the “Original Registration Statement”), with the U.S. Securities and Exchange Commission (the “Commission”), to register an aggregate of 1,884,687 ordinary shares, NIS 0.01 par value per share (“Ordinary Shares”), that may be issued pursuant to the Registrant’s 2015 Share Option Plan (the “Plan”), as amended from time to time.
The Registrant is filing this Registration Statement on Form S-8 with the Commission to register an additional 931,139 Ordinary Shares that may be issued under the Plan. The Registrant’s board of directors approved increasing the reservation of the aforementioned additional shares under the Plan on August 23, 2023.
Pursuant to General Instruction E to Form S-8, the contents of the Original Registration Statement are incorporated herein by reference, except for Item 3 and Item 8 of Part II of the Original Registration Statement, which are being updated by this registration statement.
PART II
ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE
The following documents filed by Wearable Devices Ltd., an Israeli company (the “Registrant”), with the U.S. Securities and Exchange Commission (the “Commission”) are incorporated by reference into this Registration Statement:
(a) (a) The Registrant’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the Commission on March 22, 2023;
(b) The Registrant’s Reports of Foreign Private Issuer on Form 6-K filed with the Commission on January 4, 2023 (with respect to the first two and the third paragraphs and the section titled “Forward-Looking Statements” only), January 10, 2023 (with respect to the first paragraph and the section titled “Forward-Looking Statements” only), February 9, 2023 (with respect to the first two paragraphs and the section titled “Forward-Looking Statements” only), February 16, 2023 (with respect to the first two paragraphs and the section titled “Forward-Looking Statements” only), March 22, 2023 (with respect to the first three and the last two paragraphs, the section titled “Forward-Looking Statements” and the GAAP financial statements only), May 23, 2023, May 25, 2023, June 1, 2023 (with respect to the first two and the fourth paragraphs and the section titled “Forward-Looking Statements” only), June 12, 2023, August 25, 2023 (with respect to the first paragraph the sections titled “Financial Review,” “Year-To-Date Operational Highlights,” and “Forward-Looking Statements” and the financial statements in the press release attached as Exhibit 99.1 to the Form 6-K), August 29, 2023 and August 31, 2023; and
(c) The description of the Registrant’s ordinary shares, NIS 0.01 par value per share, (the “Ordinary Shares”),which is contained in the Registrant’s Registration Statement on Form 8-A filed on September 9, 2022 (File No. 001-41502) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including any amendment or report filed for the purpose of updating such description.
All documents, reports and definitive proxy or information statements filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act and all reports on Form 6-K subsequently filed by the Registrant which state that they are incorporated by reference herein on or after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement that indicates that all securities offered hereby have been sold or that deregisters all securities then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of filing of such documents. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document that also is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
Item 8. EXHIBITS.
* | Filed herewith. |
II-1
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-1 and has duly caused this registration statement on Form S-8 to be signed on its behalf by the undersigned, thereunto duly authorized, in Yokne’am Illit, Israel, on September 5, 2023.
WEARABLE DEVICES LTD. | ||
By: | /s/ Asher Dahan | |
Asher Dahan | ||
Chief Executive Officer |
The undersigned officers and directors of Wearable Devices Ltd. hereby constitute and appoint each of Asher Dahan and Alon Mualem with full power of substitution, each of them singly his true and lawful attorneys-in-fact and agents to take any actions to enable Wearable Devices Ltd. to comply with the Securities Act, and any rules, regulations and requirements of the SEC, in connection with this registration statement on Form S-8, including the power and authority to sign for the undersigned in his name in the capacities indicated below any and all further amendments to this registration statement and any other registration statement filed pursuant to the provisions of Rule 462 under the Securities Act.
Pursuant to the requirements of the Securities Act of 1933, this amendment to the registration statement on Form S-8 has been signed by the following persons in the capacities and on the dates indicated.
Signature | Title | Date | ||
/s/ Asher Dahan | Chief Executive Officer, Director | September 5, 2023 | ||
Asher Dahan | (Principal Executive Officer) | |||
/s/ Alon Mualem | Chief Financial Officer | September 5, 2023 | ||
Alon Mualem | (Principal Financial and Accounting Officer) | |||
/s/ Eli Bachar | Director | September 5, 2023 | ||
Eli Bachar | ||||
/s/ Yaacov Goldman | Director | September 5, 2023 | ||
Yaacov Goldman | ||||
/s/ Ilana Lurie | Director | September 5, 2023 | ||
Ilana Lurie | ||||
/s/ Guy Wagner | Director | September 5, 2023 | ||
Guy Wagner |
II-2
SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES
Pursuant to the Securities Act of 1933, as amended, the undersigned, Mudra Wearable, Inc., the duly authorized representative in the United States of Wearable Devices Ltd., has signed this registration statement on September 5, 2023.
/s/ Mudra Wearable, Inc. | |
Mudra Wearable, Inc. |
II-3
This ‘S-8’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / Effective on: | 9/5/23 | |||
8/23/23 | ||||
3/22/23 | 20-F, 6-K | |||
2/17/23 | CORRESP, POS AM, S-8 | |||
12/31/22 | 20-F | |||
9/9/22 | 8-A12B, CORRESP | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/24/24 Wearable Devices Ltd. 6-K 4/24/24 2:31K EdgarAgents LLC/FA 3/15/24 Wearable Devices Ltd. 6-K 3/15/24 2:113K EdgarAgents LLC/FA 11/30/23 Wearable Devices Ltd. 6-K 11/30/23 1:12K EdgarAgents LLC/FA 11/13/23 Wearable Devices Ltd. 6-K 11/13/23 5:420K EdgarAgents LLC/FA 11/09/23 Wearable Devices Ltd. 6-K 11/08/23 2:20K EdgarAgents LLC/FA 10/26/23 Wearable Devices Ltd. 6-K 10/26/23 2:133K EdgarAgents LLC 2/FA 10/24/23 Wearable Devices Ltd. 6-K 10/24/23 2:44K EdgarAgents LLC 2/FA |